Business Context and Reporting Period
Company: DarioHealth Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: July 9, 2019
Date of Earliest Event: July 8, 2019
Context: The filing reports a material modification to the rights of security holders regarding pre-funded warrants issued in a public offering on May 24, 2019.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a disclosure of a contractual amendment.
Material Changes
- Event: Amendment to Pre-Funded Warrants.
- Scope: Applies to holders of pre-funded warrants to purchase up to 7,175,525 shares of common stock.
- Modification: The terms were amended to include a $100,000 limitation on any potential buy-in penalty previously provided for in the warrant agreements.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific amendment to the warrant terms. The description of the amendment is qualified by reference to Exhibit 4.1.
Investor Verification Checklist
- Verify the full text of the "Form of Amendment to Pre-Funded Warrant" (Exhibit 4.1) to understand the specific conditions of the $100,000 buy-in penalty limitation.
- Confirm the total number of pre-funded warrants outstanding (7,175,525) and their impact on potential dilution.
- Review the original May 24, 2019 public offering documents to compare the original buy-in penalty terms against the new limitation.